Grunenthal Logo

External Link

You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.

Title
Description
Trial IDKF5503-66
CompoundTapentadol
Trials sponsorGrünenthal GmbH
Trial phase2
Brief titleA study to look at Tapentadol Tablets in Children and Adolescents in pain
IndicationPain in Children, Pain in Adolescents
UTNU1111-1154-4572
CTG IDNCT02151682
CTIS ID (former EudraCT)2012-004360-22
Trial statusCompleted
FPIApril 29, 2015
LPOOctober 15, 2018
CountriesHungary, Latvia, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Ukraine
GenderAll
Age>= 18 years of age
ResultsYes
Pubmed
Documentskf5503-66-expert-summary
kf5503-66-lay-summary-bulgarian
kf5503-66-lay-summary-english
kf5503-66-lay-summary-french-be
kf5503-66-lay-summary-french-fr
kf5503-66-lay-summary-german
kf5503-66-lay-summary-hungarian
kf5503-66-lay-summary-italian
kf5503-66-lay-summary-portuguese
kf5503-66-lay-summary-spanish-cl
kf5503-66-lay-summary-spanish-es